Keith Stein Replaces Trevor Dixon and Josef Hocher on Invictus'
Board
Vancouver,
BC, Canada -- January
15,
2019 -- InvestorsHub NewsWire -- INVICTUS MD
STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA:
8IS1) is
pleased to announce that the Company's Board of
Directors (the "Board") has approved the
appointment of Keith Stein, Counsel at
Dentons Canada LLP
("Dentons"), to serve on the Board
effective January
11, 2019. The new appointment follows the resignations of Trevor
Dixon,
President and Director of Invictus since April 25,
2017,
and
Josef Hocher, member of the
Board
since
June 26,
2017.
Mr. Dixon will
remain as President and Director
of
the Company's
wholly-owned subsidiary Acreage Pharms Ltd ("Acreage
Pharms"). George E. Kveton, CEO of Invictus
will assume the
role of President of the Company.
Mr. Stein
joined Dentons as
Counsel in 2014 after serving as Counsel at Heenan Blaikie LLP from 2008 until February
2014. From
1994 to 2008, he was a senior executive with Magna
International
Inc. ("Magna") reporting to the Chairman,
Frank Stronach and continued to act as a
consultant reporting to the Executive
Vice-Chairman until November 2010. Prior to becoming a consultant,
Mr. Stein held the position of Senior
Vice-President of Corporate Affairs at Magna. Before joining
Magna, he was Senior Corporate Counsel
for Toyota Canada and Toyota Credit Canada. Mr. Stein has been a board
member of various publicly listed
companies.
"On behalf of the
Invictus, I want to thank Mr. Dixon and Mr. Hocher for their hard work and
dedication to the Company. As founder of Acreage Pharms in 2013,
Trevor has played an integral role in Invictus' growth strategy
and will continue to oversee
the expansion
of the Acreage Pharms'
facility
and its
EU-GMP
certification," said Mr. Kveton. "I am thrilled to
welcome Mr. Stein
to the Board, his wealth of
business
acumen and
experience across a wide range of
industries in Canada and abroad will be a great asset to support the
executive team and fellow Directors in executing on
the
Company's vision."
For more
information, please visit
www.invictus-md.com.
On Behalf of the
Board,
George E.
Kveton
Chief
Executive Officer and Director
Jessica
Martin
Vice
President, Public Relations and Regulatory
Affairs
(833)
879-4363
About
Invictus
Invictus is a
global cannabis company offering a selection of products under a
wide range of brands. Our integrated sales approach is defined by
five pillars of distribution including medical, adult-use,
international, Licensed Producer to Licensed Producer and retail
stores.
Invictus has
partnered with business leaders to convey our corporate vision,
including KISS music legend and business mogul Gene Simmons
as our Chief Evangelist Officer. To meet growing demand, Invictus
is expanding its cultivation footprint, with three cannabis production facilities
licensed under the Cannabis Act and
Cannabis Regulations in Canada. To accommodate international
sales, Invictus' wholly-owned subsidiary, Acreage Pharms Ltd.
("Acreage Pharms"), has designed and is currently building its
Phase 3 purpose-built cultivation facility to be European Union
Good Manufacturing Practices ("EU-GMP") compliant. The
Company is
targeting up to 50 percent of production to medical
cannabis. To ensure consistency in quality and supply, Invictus
maintains all aspects of the growing process through its
subsidiary, Future Harvest Development Ltd. ("Future
Harvest"), a
high-quality fertilizer and
nutrients
manufacturer. Invictus drives sustainable long-term shareholder
value through a diversified product portfolio with over
70
Health Canada
approved strains and a multifaceted distribution strategy including
medical, adult-use, international, Licensed Producer to Licensed
Producer and retail stores. For more information visit
www.invictus-md.com.
Neither the
Canadian Securities Exchange nor its Regulation Services Provider
accepts responsibility for the adequacy or accuracy of this
release.